Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2a Study of 0.05% Difluprednate Ophthalmic Emulsion in the Treatment of Postoperative Inflammation After Cataract Surgery

NCT00407225 is registered in ClinicalTrials.gov with Sirion Therapeutics, Inc. as lead sponsor.

NCT NCT00407225
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00407225 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2a Study of 0.05% Difluprednate Ophthalmic Emulsion in the Treatment of Postoperative Inflammation After Cataract Surgery
Lead sponsor
Sirion Therapeutics, Inc.
Phase
Phase 2
Overall status
Completed
Start date
December 31, 1999
Completion date
October 31, 2000
Enrollment
24
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

inflammation